Genetics and Molecular Biology
Occurs as a spontaneous mutation in 70% of cases. Autosomal dominantly inherited in the remaining 30% of familial cases. The disorder is associated with mutations in one of two genes, TSC1 (on 9q34) or TSC2 (on 16p13.3). The TSC1-2 protein complex acts as an intracellular complex that links a number of intracellular signalling pathways including the AMPK pathway, the MAPK pathway and the PI3K pathway. The TSC1-2 complex functions upstream of mTOR (mammalian Target Of Rapamycin). TSC mutations causes mTOR overactivation, leading to dysregulation of cell growth, proliferation and various other fundamental neurobiological processes 
Physical features and natural history
Wide variability of expression. The previously used "diagnostic triad" (of epilepsy, intellectual disability and characteristic facial skin lesions) is seen in only about 30% of people with the disorder. TSC is multisystem and can include hamartomatous growths affecting the brain, skin, kidneys, heart, eyes, teeth, lungs and other organs. About 80% of affected people have a lifetime history of epilepsy. Diagnosis is based on meeting clinical criteria for the disorder . Mutations are identified in 80-90% of individuals with clinically confirmed TSC.
TSC is not an inevitably declining condition and any deterioration in physical, neurocognitive and behavioural profile should be further investigated. Life expectancy is influenced by the degree of physical and neurological involvement. Intractable seizures, brain tumours (SEGAs -subependymal giant cell astrocytomas) and renal failure secondary to angiomyolipomas may be causes of death.
Behavioural and psychiatric characteristics
Tuberous Sclerosis is associated with a wide range of behavioural, psychiatric, intellectual, academic, neuropsychological and psychosocial difficulties. The term TAND (TSC-Associated Neuropsychiatric Disorders) has been introduced as a summary term for all the bio-psycho-social aspects of the disorder 
Neuropsychological characteristics
Global intellectual abilities show a bimodal distribution in TSC. 30% of individuals with TSC have profound global intellectual disability (IQ equivalent <20) and do not show significant developmental gains over time. The remaining 70% fall on a normal distribution curve, shifted to the left. In clinical practice, more than 50% of individuals with TSC will have global intellectual abilities in the normal range. There are, however, high rates of specific neuropsychological deficits in those with normal global intellectual abilities. Specific deficits are most prominent in attentional, executive and visuo-spatial skills. These specific cognitive deficits may be associated with significant scholastic difficulties and impair functional abilities in daily life 
